Market Place
Sourcing Support
Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
08 Aug 2024 //
GLOBENEWSWIRE
Cassava Sciences Announces Expansion of Open-Label Extension Trials
30 Jul 2024 //
GLOBENEWSWIRE
Cassava Sciences Issues Statement on Former Science Advisor
28 Jun 2024 //
GLOBENEWSWIRE
Cassava Sciences Q1 2024 Financials, Simufilam Phase 3 Updates
10 May 2024 //
GLOBENEWSWIRE
Cassava Announces Completion of Safety Review of Oral Simufilam Pha 3 Trials
25 Mar 2024 //
GLOBENEWSWIRE
Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam
06 Nov 2023 //
GLOBENEWSWIRE
MRI Data Suggest Simufilam is Not Associated with ARIA
25 Oct 2023 //
GLOBENEWSWIRE
Cassava Completes Patient Enrollment for Phase 3 Trial of Oral Simufilam
02 Oct 2023 //
GLOBENEWSWIRE
Cassava Announces Positive Safety Review of Simufilam Phase 3 Trials
18 Sep 2023 //
GLOBENEWSWIRE
Cassava Announces Publication That Confirms Mechanism of Action of Simufilam
11 Sep 2023 //
GLOBENEWSWIRE
Oral Simufilam Slowed Cognitive Decline in a Trial of Alzheimer`s Disease
05 Jul 2023 //
GLOBENEWSWIRE
Why Shares of Cassava Sciences Jumped This Week
12 May 2023 //
FOOL
Cassava Completes Patient Dosing in a Randomized Controlled Trial of Simufilam
11 May 2023 //
GLOBENEWSWIRE
Cassava Announces Patient Enrollment Update for Phase 3 Studies of Simufilam
08 Feb 2023 //
GLOBENEWSWIRE
Cassava Sciences Announces Positive Results in PII Study Evaluating Simufilam
24 Jan 2023 //
GLOBENEWSWIRE
Cassava Sciences Announces Completion of Dosing in Open-label of Simufilam for AD
06 Dec 2022 //
GLOBENEWSWIRE
Cassava Sciences Announces Initiation of an Open-label Extension Study
13 Oct 2022 //
GLOBENEWSWIRE
Cassava Sciences Launches Clinical Website to Support Ph3 Studies Oral Simufilam
23 Dec 2021 //
GLOBENEWSWIRE
Cassava Sciences Launches Clinical Website to Support Ph3 Studies Oral Simufilam
23 Dec 2021 //
GLOBENEWSWIRE
Cassava starts another Alzheimer`s med trial amid fed inquiries
19 Nov 2021 //
FIERCEBIOTECH
Cassava Sciences under SEC Investigation for data manipulation
18 Nov 2021 //
ENDPTS
Cassava being investigated by unnamed `government agencies`; And more
15 Nov 2021 //
ENDPTS
Cassava drops interim Alzheimer`s data with plenty of caveats
23 Sep 2021 //
FIERCEBIOTECH
Cassava Sciences Announces Top-line Results of 12-month Interim Analysis
22 Sep 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.